Skip to main content

Jonathan Wall receives $1.79 million to develop amyloidosis treatment

Research

By BIOENGINEER – March 16, 2021

Memphis, Tenn. (March 16, 2021) – The National Institute of Diabetes and Digestive and Kidney Diseases recently awarded Jonathan Wall, PhD, professor in the University of Tennessee Health Science Center’s Graduate School of Medicine in Knoxville, a $1.79 million grant for his study titled “Developing a Theranostic Immunotherapy for Systemic Amyloidosis.”

Read the full article here.